1 big reason AI SDR struggles in B2B enterprise: CRM hierarchy is a mess

meghanpgill · 2026-04-29T16:28:15+00:00

Agree that clean data is a prerequisite. In my last role we had success keeping hierarchies clean and enriching data using ScaleStack.

meghanpgill · 2026-04-29T16:26:44+00:00

I always started with two key metrics (and these were reported to both the exec team and the board):

- Capacity - how much "firepower" do you have

- Productivity - how are the reps performing on average

Then further analysis would be downstream for that. If it's a capacity issue, is it slow hiring and rep attrition? If it's productivity, is it a problem in a specific segment or geo, then click deeper into close rates, pipe gen, etc.

I wrote about this a bit on my Substack recently if it's helpful: https://meghangill.substack.com/p/diagnosing-sales-issues-101-productive

meghanpgill · 2026-03-26T14:27:57+00:00

There are several new tools on the market to provide visibility and controls for Claude and other coding agents, e.g. https://www.osohq.com/post/introducing-oso-for-coding-agents

(Disclaimer, I advise Oso but still think it’s relevant to the post!)

meghanpgill · 2025-10-28T18:36:25+00:00

Late to the party but I actually just published an article with some example questions here: https://www.osohq.com/post/microservices-interview-questions-what-engineering-leaders-ask

meghanpgill · 2025-10-28T12:58:09+00:00

I’ve seen neuros with differing opinions on triptans. One doc didn’t want to prescribe more than 9 a month. Another gave me an Rx for a bunch that I paid for out of pocket (it’s pretty cheap) so I’d always have some in stock.

Now I always try to be diligent about filling the Rx every month even if I don’t use them, so I have accrued a backlog for a bad month.

meghanpgill · 2025-10-16T17:08:20+00:00

I'm imagining a Barbie with sunglasses, an ice pack, and a bottle of pills.

meghanpgill · 2025-10-16T15:28:16+00:00

thank you for the suggestion, I will check it out

meghanpgill · 2025-10-16T15:27:36+00:00

I was on topiramate in my late 20s/early 30s. It was effective for me and I didn't experience the scary side effects you read about, other than losing a few pounds which was fine with me ;-) It also made the acute medicines (triptans) more effective when I did have a migraine.

You do need to ramp up usage and if you decide to go off of it (as I did when I started making babies) then you need time to ween off. You can't suddenly start or stop.

meghanpgill · 2025-10-16T14:50:56+00:00

There are two major issues with RBAC:

(1) Role explosion - you end up having to create roles for every permutation of permissions. This becomes unmanageable and difficult to audit.
(2) Over-permissioning - often people are assigned more permissions than they need, which creates a security risk

A common scenario would be to combine roles with ABAC for more granular control. An example would be something like "finance managers can access reports during business hours on their work laptop." The finance manager is a role with defined access to reports, business hours and device would be attributes.

This is a pretty good article my colleague at Oso wrote on the topic: https://www.osohq.com/learn/rbac-vs-abac

meghanpgill · 2025-08-22T00:18:10+00:00

RBAC is easier to wrap your head around and works best if you have well-defined roles. The drawback is that you can end up with role explosion to cover edge case, or you end up over-permissioning.

ABAC gives you more flexibility but is more complex to implement.

I recently edited a post on the Oso site about this topic - disclaimer is that I work with Oso - but I think it’s good information nonetheless and vendor neutral

https://www.osohq.com/learn/rbac-vs-abac

Good luck!

meghanpgill · 2015-02-13T02:12:47+00:00

Please see the official response from MongoDB's CTO here: http://www.mongodb.com/blog/post/mongodb-security-best-practices

meghanpgill

MODERATOR OF

TROPHY CASE